Contact:
William F. Hackett
Base Ten Systems, Inc.
(609) 586-7010 Ext. 2310

                          BASE TEN COMPLETES FINANCING
                               Raises $20,000,000


TRENTON,  N.J.  November  13,  1998 - Base Ten  Systems,  Inc.  (Nasdaq:  BASEA)
announced  today that it had  completed the sale of  $20,000,000  worth of newly
issued  common  shares  at a price of $3.00  per  share.  The  transaction  also
included warrants good for seven years to purchase  1,000,000  additional shares
of Base Ten  Series A common  stock at $3.00 per  share.  Base Ten  shareholders
approved the  transaction at a Special  Meeting of  Shareholders on November 10,
1998.

Thomas E.  Gardner,  chairman and chief  executive  officer of Base Ten Systems,
said,  "This infusion of capital should give us the resources  needed to execute
current  growth plans.  The Company is well  positioned as a leader in solutions
level software and services for companies that are subject to cGMP (current Good
Manufacturing  Practice)  regulation  as  promulgated  by the  U.S.  Food & Drug
Administration. It is now up to our management and professional teams to execute
our strategies well."*

Base Ten Systems is a leading software technology company,  focused on execution
systems and services for the pharmaceutical, fine chemicals and medical products
industries. Through installation of BASE10(TM) software, the company's customers
around  the world can  enjoy  more  effective  regulatory  compliance,  improved
manufacturing   flexibility  and  reduced  production  cycle  time.   BASE10(TM)
execution systems are readily integrated with complementary software partners as
manufacturers  consolidate  their operations into global supply chain processes.
You can  learn  more  about  Base  Ten  Systems  by  visiting  its  web  site at
www.base10.com.*

*Forward Looking Statements

The foregoing contains "forward looking  information"  within the meaning of The
Private  Securities   Litigation  Reform  Act  of  1995.  Such  forward  looking
statements  may be  identified by an asterisk  ("*") or by such forward  looking
terminology as "may",  "will",  "believe",  "anticipate",  "expect",  or similar
words or variations  thereof.  Such forward looking  statements  involve certain
significant risks and uncertainties. Important factors that the Company believes
may  cause  actual  results  to differ  materially  from  such  forward  looking
statements are discussed in the "Risk  Factors,"  "Business" and "MD&A" sections
of the Company's  current S-3  registration  statements and annual and quarterly
reports on file with the Securities  and Exchange  Commission.  Additional  risk
factors include the effectiveness of the software and ability of the software to
operate without "bugs" in the technology, acceptance of the release by customers
and actual rollout as a result of the release. In assessing such forward looking
statements you are urged to read carefully those reports and other filings.  The
Company  does not  undertake  to publicly  update or revise its forward  looking
statements  even if experience or future changes  indicate that any such results
or event (expressed or implied) will not be realized.

                                     # # #